Related Tags >> GlaxoSmithKline FDA Entereg Phase II

Adolor News

Most Popular Adolor Story

Pfizer, Adolor ink pain drug deal

December 5, 2007 — 7:59am ET

Continuing on its deal-making quest, Pfizer has signed an agreement with Exton, PA-based Adolor for ADL5859 and ADL5747. The two pain drugs... Read more...

Adolor Press Releases

Adolor Regains Rights to Entereg® (alvimopan) for OBD
PRESS RELEASE: Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
PRESS RELEASE: Adolor Corporation Says FDA Continues Clinical Hold on Trial
PRESS RELEASE: FDA Accepts for Review Complete Response to Approvable Letter for Entereg for POI

Latest Headlines

Progenics, Wyeth drug fails late-stage trial
May 22, 2008
FDA OKs Adolor's Entereg in first approval
May 21, 2008
FDA delays Entereg decision
May 9, 2008
GSK, Adolor face another Entereg delay
February 11, 2008
Entereg wins key FDA advisory committee vote
January 24, 2008
Pfizer, Adolor ink pain drug deal
December 5, 2007
ALSO NOTED: Adolor shares rise on NDA news; Indevus plans Phase III; Exelixis earns milestone; and much more...
November 29, 2007
ALSO NOTED: Vernalis reports "striking" weight loss in trial; Genmab shares surge on Phase III; FDA wants more time on Entereg;
September 13, 2007
Investors cheer FDA's acceptance of Entereg response
August 28, 2007
ALSO NOTED: Judge clears Exubera sales; Obagi prices IPO; Novartis sells med nutrition business; and much more...
December 13, 2006
Adolor hit by FDA's approvable letter for Entereg
November 5, 2006
ALSO NOTED: Adolor to give back pain patch; Dynavax pursues universal flu vaccine; Charles River buys Northwest Kinetics; and m
October 30, 2006
Adolor shares in meltdown on trial data
September 4, 2006
ALSO NOTED: LAB International plans spinoff; Merck backs off Vioxx analysis; and much more...
May 30, 2006
GSK, Adolor upbeat on Phase IIb Entereg data
May 3, 2006
New trial data adds support for Entereg
February 7, 2006
ALSO NOTED: Vasopharm raises $11.8M; Adolor delays trial; Nuvelo prices shares;and much more...
January 30, 2006
C&L: Herrera named NeoPharm CEO
November 1, 2005
C&L: Alethia BioTherapeutics names Cornellier new CEO
August 2, 2005
Chutes & Ladders: Peacock resigns top post at Adolor
August 1, 2005

Paid Research Reports